期刊
ANALYTICAL BIOCHEMISTRY
卷 371, 期 2, 页码 154-161出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ab.2007.08.038
关键词
bioluminescence immunoassay; Aequorin; angiotensin II; reporter protein
资金
- PHS HHS [4-67917] Funding Source: Medline
Angiotensin II is a biologically active component of the renin-angiotensin system. High levels of angiotensin II may be responsible for hypertension and heart failure because they increase systemic vascular resistance, arterial pressure, and sodium and fluid retention. Therefore, it is important to monitor angiotensin II levels for the treatment of hypertension and heart diseases. The goal of this work was to develop a biolummiscence immunoassay using aequorin as a label to measure angiotensin II levels in human plasma. This method utilizes a genetically engineered fusion protein between angiotensin II and aequorin. For that, the C terminus of angiotensin II was fused to the N terminus of apoaequorin using molecular biology techniques. A heterogeneous immunoassay was then developed for the determination of an2iotensin II. A detection limit of I pg/mL was obtained with the optimized assay, allowing for the determination of angiotensin II at physiological levels in human plasma. (C) 2007 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据